Acarix AB (publ) (ACARIX.ST)
SEK 0.22
(1.15%)
SEK 0.22
(1.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.29 Million SEK | 14.63% |
| 2022 | 4.62 Million SEK | 63.69% |
| 2021 | 2.82 Million SEK | 77.1% |
| 2020 | 1.59 Million SEK | 11.47% |
| 2019 | 1.43 Million SEK | 101.98% |
| 2018 | 708 Thousand SEK | 64.65% |
| 2017 | 430 Thousand SEK | 0.0% |
| 2016 | - SEK | 100.0% |
| 2015 | -8.67 Million SEK | 54.11% |
| 2014 | -18.9 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.41 Million SEK | 37.55% |
| 2024 Q2 | 1.06 Million SEK | 26.52% |
| 2023 Q4 | 1.02 Million SEK | -20.43% |
| 2023 FY | 5.29 Million SEK | 14.63% |
| 2023 Q2 | 1.29 Million SEK | -23.53% |
| 2023 Q3 | 1.29 Million SEK | 0.16% |
| 2023 Q1 | 1.68 Million SEK | 26.94% |
| 2022 Q2 | 1.31 Million SEK | 25.07% |
| 2022 FY | 4.62 Million SEK | 63.69% |
| 2022 Q1 | 1.05 Million SEK | 45.24% |
| 2022 Q4 | 1.32 Million SEK | 44.3% |
| 2022 Q3 | 921 Thousand SEK | -30.07% |
| 2021 FY | 2.82 Million SEK | 77.1% |
| 2021 Q2 | 632 Thousand SEK | 19.25% |
| 2021 Q3 | 936 Thousand SEK | 48.1% |
| 2021 Q4 | 725 Thousand SEK | -22.54% |
| 2021 Q1 | 530 Thousand SEK | -25.56% |
| 2020 Q3 | 552 Thousand SEK | 150.91% |
| 2020 FY | 1.59 Million SEK | 11.47% |
| 2020 Q4 | 712 Thousand SEK | 28.99% |
| 2020 Q2 | 220 Thousand SEK | 101.83% |
| 2020 Q1 | 109 Thousand SEK | -82.04% |
| 2019 Q3 | 74 Thousand SEK | -86.27% |
| 2019 Q4 | 607 Thousand SEK | 720.27% |
| 2019 FY | 1.43 Million SEK | 101.98% |
| 2019 Q1 | 209 Thousand SEK | 57.14% |
| 2019 Q2 | 539 Thousand SEK | 157.89% |
| 2018 Q1 | 158 Thousand SEK | -8.67% |
| 2018 FY | 708 Thousand SEK | 64.65% |
| 2018 Q4 | 133 Thousand SEK | -41.15% |
| 2018 Q3 | 226 Thousand SEK | 18.32% |
| 2018 Q2 | 191 Thousand SEK | 20.89% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 Q2 | 116 Thousand SEK | 0.0% |
| 2017 Q3 | 140 Thousand SEK | 20.69% |
| 2017 FY | 430 Thousand SEK | 0.0% |
| 2017 Q4 | 173 Thousand SEK | 23.57% |
| 2016 Q3 | - SEK | 0.0% |
| 2016 Q1 | - SEK | 100.0% |
| 2016 FY | - SEK | 100.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2015 Q4 | -1.49 Million SEK | 0.0% |
| 2015 FY | -8.67 Million SEK | 54.11% |
| 2014 FY | -18.9 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ADDvise Group AB (publ) | 300.6 Million SEK | 98.238% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 98.238% |
| Arcoma AB | 11.07 Million SEK | 52.154% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | 96.216% |
| BICO Group AB (publ) | 1.83 Billion SEK | 99.711% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | 97.879% |
| CellaVision AB (publ) | 463.04 Million SEK | 98.856% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -76.743% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 118.642% |
| C-Rad AB (publ) | 66.01 Million SEK | 91.976% |
| Duearity AB (publ) | -4.17 Million SEK | 226.783% |
| Dignitana AB (publ) | 58.97 Million SEK | 91.018% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 112.672% |
| Getinge AB (publ) | 13.43 Billion SEK | 99.961% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 110.548% |
| Iconovo AB (publ) | 17.57 Million SEK | 69.865% |
| Integrum AB (publ) | 690.56 Thousand SEK | -667.056% |
| Luxbright AB (publ) | -2.79 Million SEK | 289.39% |
| Mentice AB (publ) | 236.38 Million SEK | 97.759% |
| OssDsign AB (publ) | 83.64 Million SEK | 93.667% |
| Paxman AB (publ) | 12.61 Million SEK | 58.02% |
| Promimic AB (publ) | 38.51 Million SEK | 86.247% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 110.437% |
| SciBase Holding AB (publ) | 16.03 Million SEK | 66.97% |
| ScandiDos AB (publ) | 47.55 Million SEK | 88.861% |
| Sectra AB (publ) | 557.55 Million SEK | 99.05% |
| Sedana Medical AB (publ) | 108.98 Million SEK | 95.14% |
| Senzime AB (publ) | 8.33 Million SEK | 36.479% |
| SpectraCure AB (publ) | -9.22 Million SEK | 157.433% |
| Stille AB | 132.17 Million SEK | 95.992% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 99.732% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | 98.729% |